1. Lin, Ritian, Wu, Wei, Chen, Huimin, Sun, Mingming, Liu, Zhanju. . GPR65 promotes intestinal mucosal Th1 and Th17 cell differentiation and gut inflammation through downregulating NUAK2. In Clinical and translational medicine, 12, e771. doi:10.1002/ctm2.771. https://pubmed.ncbi.nlm.nih.gov/35343079/
2. Marie, Mona A, Sanderlin, Edward J, Satturwar, Swati, Donthi, Deepak, Yang, Li V. 2021. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models. In Biochimica et biophysica acta. Molecular basis of disease, 1868, 166288. doi:10.1016/j.bbadis.2021.166288. https://pubmed.ncbi.nlm.nih.gov/34628032/
3. Mao, Jia, Feng, Ying, Zheng, Yayun, Zhu, Xiaofeng, Ma, Fang. 2023. GPR65 inhibits human trophoblast cell adhesion through upregulation of MYLK and downregulation of fibronectin via cAMP-ERK signaling in a low pH environment. In Cell communication and signaling : CCS, 21, 238. doi:10.1186/s12964-023-01249-3. https://pubmed.ncbi.nlm.nih.gov/37723567/
4. Fan, Jikang, Liu, Jie, Zhang, Bin, Li, Tao, Yang, Xuejun. 2024. GPR65 contributes to constructing immunosuppressive microenvironment in glioma. In Neurosurgical review, 47, 417. doi:10.1007/s10143-024-02633-4. https://pubmed.ncbi.nlm.nih.gov/39123083/
5. Qi, Jin, Liu, Sihang, Zhang, Zhirui. 2024. What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance. In Cancer cell international, 24, 31. doi:10.1186/s12935-024-03216-5. https://pubmed.ncbi.nlm.nih.gov/38218960/
智鼠故事 
